Novartis headquarters in Basel
|
|
Public company AG | |
Traded as |
SIX: NOVN, : NVS : (A Subsidiary - Novartis India Ltd.) |
Industry | Pharmaceuticals |
Founded | 1996 (from merger) |
Headquarters | Basel, Switzerland |
Area served
|
Worldwide |
Key people
|
Joerg Reinhardt (Chairman), Joseph Jimenez (CEO) |
Products | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...) |
Revenue | US$50.359 billion (2015) |
US$8.845 billion (2015) | |
US$17.783 billion (2015) | |
Total assets | US$131.55 billion (2015) |
Total equity | US$77.046 billion (2015) |
Number of employees
|
118,700 (2015) |
Subsidiaries | Ciba Vision, Sandoz, Alcon, Chiron Corporation |
Website | www |
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market cap and sales.
Novartis manufactures such drugs as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and imatinib mesylate (Gleevec/Glivec). Additional agents include ciclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others.
In 1996, Ciba-Geigy merged with Sandoz, and the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. Other Ciba-Geigy and Sandoz businesses were sold, or like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for 3 years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca, which also divested its agrochemical business.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA).